title: Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patients.
authors.forename: N
authors.initials: N
authors.lastname: Magné
authors.forename: X
authors.initials: X
authors.lastname: Pivot
authors.forename: M C
authors.initials: MC
authors.lastname: Etienne-Grimaldi
authors.forename: E
authors.initials: E
authors.lastname: François
authors.forename: N
authors.initials: N
authors.lastname: Renée
authors.forename: A
authors.initials: A
authors.lastname: Thyss
authors.forename: M
authors.initials: M
authors.lastname: Schneider
authors.forename: F
authors.initials: F
authors.lastname: Demard
authors.forename: G
authors.initials: G
authors.lastname: Milano
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D042943:Dihydrouracil Dehydrogenase (NADP); D004347:Drug Interactions; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010088:Oxidoreductases / Q000187:drug effects / Q000378:metabolism*; D011379:Prognosis; D011446:Prospective Studies; D012494:Sampling Studies; D016896:Treatment Outcome
chemical_list: D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D002945:Cisplatin; D005472:Fluorouracil